BACKGROUND: glucocorticoid receptor-9β polymorphism (rs6198) is associated with the susceptibility for cardiovascular disease. AIM: to examine whether the GR-9 β variant is also associated with blood pressure and heart growth in early childhood. STUDY DESIGN: this study was embedded in a population-based prospective cohort study from fetal life onwards. Analyses were based on 857 children. OUTCOME MEASURES: Left cardiac structures (aortic root diameter, left atrial diameter and left ventricular mass), shortening fraction and heart beat were measured postnatally at the ages of 1.5, 6 and 24 months. Blood pressure was measured at 24 months of age. RESULTS: the distribution of the GR-9β genotype showed 75.1% homozygous reference, 23.5% heterozygous and 1.4% homozygous variant subjects. No differences in cardiovascular outcomes were observed at the ages of 1.5 and 6 months. At the age of 24 months, homozygous variants showed an increased systolic blood pressure of 2.65 mmHg (95% CI: 0.16, 5.14), an increased heart rate of 9.10 beats per minute (95% CI: 1.28, 16.7) and an increased left ventricular mass of 4.99 g (95% CI: 1.33, 8.65) compared to homozygous references. This means an increase of 2.6%, 8.6% and 16%, respectively. GR-9 β polymorphism was significantly associated with left ventricular mass growth during the first 2 years. CONCLUSION: our findings suggest that genetically determined differences in cortisol exposure affect cardiovascular development in early life. 2010 Elsevier Ltd. All rights reserved.
BACKGROUND: glucocorticoid receptor-9β polymorphism (rs6198) is associated with the susceptibility for cardiovascular disease. AIM: to examine whether the GR-9 β variant is also associated with blood pressure and heart growth in early childhood. STUDY DESIGN: this study was embedded in a population-based prospective cohort study from fetal life onwards. Analyses were based on 857 children. OUTCOME MEASURES: Left cardiac structures (aortic root diameter, left atrial diameter and left ventricular mass), shortening fraction and heart beat were measured postnatally at the ages of 1.5, 6 and 24 months. Blood pressure was measured at 24 months of age. RESULTS: the distribution of the GR-9β genotype showed 75.1% homozygous reference, 23.5% heterozygous and 1.4% homozygous variant subjects. No differences in cardiovascular outcomes were observed at the ages of 1.5 and 6 months. At the age of 24 months, homozygous variants showed an increased systolic blood pressure of 2.65 mmHg (95% CI: 0.16, 5.14), an increased heart rate of 9.10 beats per minute (95% CI: 1.28, 16.7) and an increased left ventricular mass of 4.99 g (95% CI: 1.33, 8.65) compared to homozygous references. This means an increase of 2.6%, 8.6% and 16%, respectively. GR-9 β polymorphism was significantly associated with left ventricular mass growth during the first 2 years. CONCLUSION: our findings suggest that genetically determined differences in cortisol exposure affect cardiovascular development in early life. 2010 Elsevier Ltd. All rights reserved.
Authors: Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe Journal: Eur J Epidemiol Date: 2014-12-21 Impact factor: 8.082
Authors: Robert H Oakley; Diana Cruz-Topete; Bo He; Julie F Foley; Page H Myers; Xiaojiang Xu; Celso E Gomez-Sanchez; Pierre Chambon; Monte S Willis; John A Cidlowski Journal: Sci Signal Date: 2019-04-16 Impact factor: 8.192
Authors: Robert H Oakley; Rongqin Ren; Diana Cruz-Topete; Gary S Bird; Page H Myers; Michael C Boyle; Michael D Schneider; Monte S Willis; John A Cidlowski Journal: Proc Natl Acad Sci U S A Date: 2013-09-30 Impact factor: 11.205
Authors: Rachel V Richardson; Emma J Batchen; Adrian J W Thomson; Rowan Darroch; Xinlu Pan; Eva A Rog-Zielinska; Wiktoria Wyrzykowska; Kathleen Scullion; Emad A S Al-Dujaili; Mary E Diaz; Carmel M Moran; Christopher J Kenyon; Gillian A Gray; Karen E Chapman Journal: J Endocrinol Date: 2017-01-05 Impact factor: 4.286